Literature DB >> 11759895

Expression of the prothymosin-a gene as a prognostic factor in lung cancer.

H Sasaki1, M Nonaka, Y Fujii, Y Yamakawa, I Fukai, M Kiriyama, M Sasaki.   

Abstract

Prothymosin-alpha (PTalpha) is known to play a role in cell proliferation, and the PTalpha mRNA level may reflect the degree of proliferation of tumor cells. It has been reported that PTalpha mRNA levels are higher in human colon and liver cancer tissues than in the adjacent normal tissues. We examined the mRNA levels of PTalpha and c-myc in 20 lung cancers, using Bas 2500Mac systems. The PTalpha and c-myc mRNA levels in lung cancer tissues were higher than those in normal lung tissues; however, the PTalpha mRNA levels did not correlate with the stage or pathological subtype of the lung cancer and there was no correlation between the expression of PTalpha and c-myc. PTalpha mRNA overexpression in lung cancer was correlated with a poor prognosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11759895     DOI: 10.1007/s005950170040

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  13 in total

Review 1.  Roles of thymosins in cancers and other organ systems.

Authors:  Changyi Chen; Min Li; Hui Yang; Hong Chai; William Fisher; Qizhi Yao
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

2.  KEAP1 gene mutations and NRF2 activation are common in pulmonary papillary adenocarcinoma.

Authors:  Qing Kay Li; Anju Singh; Shyam Biswal; Frederic Askin; Edward Gabrielson
Journal:  J Hum Genet       Date:  2011-01-20       Impact factor: 3.172

3.  Effectiveness of gene expression profiling for response prediction of rectal cancer to preoperative radiotherapy.

Authors:  Eiki Ojima; Yasuhiro Inoue; Chikao Miki; Masaki Mori; Masato Kusunoki
Journal:  J Gastroenterol       Date:  2007-09-25       Impact factor: 7.527

4.  Transgenic expression of prothymosin alpha on zebrafish epidermal cells promotes proliferation and attenuates UVB-induced apoptosis.

Authors:  Chiung-Wen Pai; Yau-Hung Chen
Journal:  Transgenic Res       Date:  2009-12-11       Impact factor: 2.788

5.  Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry.

Authors:  Ranju Ralhan; Leroi V Desouza; Ajay Matta; Satyendra Chandra Tripathi; Shaun Ghanny; Siddartha Datta Gupta; Sudhir Bahadur; K W Michael Siu
Journal:  Mol Cell Proteomics       Date:  2008-03-13       Impact factor: 5.911

6.  Increased expression of prothymosin-α, independently or combined with TP53, correlates with poor prognosis in colorectal cancer.

Authors:  Meng Zhang; Feifei Cui; Su Lu; Huijun Lu; Tao Jiang; Jian Chen; Xuemei Zhang; Yubiao Jin; Zhihai Peng; Huamei Tang
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

7.  Overexpression of prothymosin alpha predicts poor disease outcome in head and neck cancer.

Authors:  Satyendra Chandra Tripathi; Ajay Matta; Jatinder Kaur; Jorg Grigull; Shyam Singh Chauhan; Alok Thakar; Nootan Kumar Shukla; Ritu Duggal; Ajoy Roy Choudhary; Siddhartha Dattagupta; Mehar Chand Sharma; Ranju Ralhan; K W Michael Siu
Journal:  PLoS One       Date:  2011-05-05       Impact factor: 3.240

8.  Overexpression of prothymosin-α in glioma is associated with tumor aggressiveness and poor prognosis.

Authors:  Anurag Kumar; Vikas Kumar; Mohit Arora; Manish Kumar; Prajwal Ammalli; Bhaskar Thakur; Jitender Prasad; Sarita Kumari; Mehar Chand Sharma; Shashank Sharad Kale; Shyam S Chauhan
Journal:  Biosci Rep       Date:  2022-04-29       Impact factor: 3.976

9.  Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer.

Authors:  Anju Singh; Vikas Misra; Rajesh K Thimmulappa; Hannah Lee; Stephen Ames; Mohammad O Hoque; James G Herman; Stephen B Baylin; David Sidransky; Edward Gabrielson; Malcolm V Brock; Shyam Biswal
Journal:  PLoS Med       Date:  2006-10       Impact factor: 11.069

10.  Keap1 mutations in lung cancer patients.

Authors:  Hidefumi Sasaki; Ayumi Suzuki; Masayuki Shitara; Katsuhiro Okuda; Yu Hikosaka; Satoru Moriyama; Motoki Yano; Yoshitaka Fujii
Journal:  Oncol Lett       Date:  2013-06-26       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.